XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 50 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,908,000 | -51.9% | 682,365 | -35.2% | 0.00% | -50.0% |
| Q4 2020 | $6,048,000 | +40.3% | 1,053,683 | +41.5% | 0.00% | 0.0% |
| Q3 2020 | $4,312,000 | +53800.0% | 744,887 | +24729.6% | 0.00% | – |
| Q2 2020 | $8,000 | -66.7% | 3,000 | -11.4% | 0.00% | – |
| Q4 2019 | $24,000 | +4.3% | 3,385 | +45.0% | 0.00% | – |
| Q3 2019 | $23,000 | -11.5% | 2,335 | +4.1% | 0.00% | – |
| Q2 2019 | $26,000 | +1200.0% | 2,242 | +2285.1% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 94 | +104.3% | 0.00% | – |
| Q3 2018 | $1,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $8,970,000 | 0.44% |
| Alpine Global Management, LLC | 370,000 | $907,000 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 460,500 | $1,128,000 | 0.17% |
| IHT Wealth Management, LLC | 334,367 | $819,000 | 0.07% |
| Redmile Group, LLC | 1,358,825 | $3,329,000 | 0.06% |
| GPS Wealth Strategies Group, LLC | 58,025 | $142,000 | 0.04% |
| Granahan Investment Management | 465,049 | $1,139,000 | 0.02% |
| SEARLE & CO. | 20,000 | $49,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 402,300 | $986,000 | 0.02% |
| Gladstone Institutional Advisory LLC | 53,500 | $131 | 0.01% |